🇺🇸 FDA
Patent

US 8263661

Development of new selective estrogen receptor modulators

granted A61PA61P15/00A61P15/12

Quick answer

US patent 8263661 (Development of new selective estrogen receptor modulators) held by The Regents of the University of California expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P15/00, A61P15/12, A61P19/00, A61P19/02